Fortrea Holdings (FRA:K67) YoY EBITDA Growth : -146.48% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Fortrea Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -146.48%.

Fortrea Holdings's EBITDA per Share for the three months ended in Mar. 2024 was €-0.19.

Fortrea Holdings YoY EBITDA Growth Historical Data

The historical data trend for Fortrea Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings YoY EBITDA Growth Chart

Fortrea Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

47.18

16.19

-50.95

Fortrea Holdings Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial						-41.21	-41.22	-60.61	-74.03	-146.48

Fortrea Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Fortrea Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(1.728	-	3.523)	/	\| 3.523 \|
=	-50.95 %

Fortrea Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.185	-	0.398)	/	\| 0.398 \|
=	-146.48 %

Fortrea Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortrea Holdings (FRA:K67) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

FTRE:USA

Address

8 Moore Drive, Durham, NC, USA, 27709

Website

https://www.fortrea.com

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings (FRA:K67) Headlines

No Headlines